| |
| |
|
| Insider
Information: |
Barasch Richard A |
| Relationship: |
Director |
| City: |
Rye Brook |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
829,107 |
|
|
Indirect Shares
|
3,672,508 |
|
|
| Direct
Value |
$7,900,836 |
|
|
|
Indirect Value
|
$36,908,707 |
|
|
| Total
Shares |
4,501,615 |
|
|
| Total
Value |
$44,809,543 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
4
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 18.3%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Universal American Financial Corp |
UAM |
Chief Executive Office... |
2017-04-28 |
0 |
2017-04-28 |
0 |
Premium* |
|
|
DFB Healthcare Acquisitions Corp |
DFBHU |
Interim CEO, Director |
2024-05-07 |
441,914 |
2019-12-16 |
3,672,500 |
Premium* |
|
|
Caremax Class A |
CMAX |
Director |
2021-06-08 |
50,000 |
2021-06-08 |
0 |
Premium* |
|
|
Oncology Institute |
TOIIW |
Director |
2023-12-26 |
337,193 |
2023-12-26 |
8 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
74 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| TOIIW |
Oncology Institute |
Director |
– • – |
2022-11-17 |
4/A |
A |
$0.00 |
$0 |
D/D |
65,174 |
207,193 |
0 |
- |
|
| TOIIW |
Oncology Institute |
Director |
– • – |
2022-11-17 |
4 |
A |
$0.00 |
$0 |
D/D |
22,708 |
164,727 |
0 |
- |
|
| DFBHU |
DFB Healthcare Acquisitio... |
Director |
– • – |
2023-06-22 |
4 |
A |
$0.00 |
$0 |
D/D |
25,614 |
379,521 |
0 |
- |
|
| DFBHU |
DFB Healthcare Acquisitio... |
Interim CEO |
• • – |
2023-06-26 |
4 |
A |
$0.00 |
$0 |
D/D |
17,143 |
396,664 |
0 |
- |
|
| DFBHU |
DFB Healthcare Acquisitio... |
Interim CEO |
• • – |
2023-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
13,698 |
403,454 |
0 |
- |
|
| DFBHU |
DFB Healthcare Acquisitio... |
Interim CEO |
• • – |
2023-10-31 |
4 |
A |
$0.00 |
$0 |
D/D |
22,891 |
426,345 |
0 |
- |
|
| TOIIW |
Oncology Institute |
Director |
– • – |
2023-12-26 |
4 |
A |
$0.00 |
$0 |
D/D |
80,000 |
337,193 |
0 |
- |
|
| DFBHU |
DFB Healthcare Acquisitio... |
Interim CEO |
• • – |
2023-12-29 |
4 |
A |
$0.00 |
$0 |
D/D |
22,291 |
448,636 |
0 |
- |
|
| DFBHU |
DFB Healthcare Acquisitio... |
Interim CEO |
• • – |
2024-03-02 |
4 |
A |
$0.00 |
$0 |
D/D |
21,206 |
451,632 |
0 |
- |
|
| DFBHU |
DFB Healthcare Acquisitio... |
Interim CEO |
• • – |
2024-04-30 |
4 |
A |
$0.00 |
$0 |
D/D |
8,829 |
450,461 |
0 |
- |
|
| TOIIW |
Oncology Institute |
Director |
– • – |
2023-03-17 |
4 |
B |
$0.55 |
$27,495 |
D/D |
50,000 |
257,193 |
2.39 |
- |
|
| UAM |
Universal American Financ... |
Chief Executive Officer |
• • – |
2016-02-06 |
4 |
D |
$5.70 |
$126,802 |
D/D |
(22,246) |
2,491,227 |
0 |
- |
|
| UAM |
Universal American Financ... |
Chief Executive Officer |
• • – |
2016-02-09 |
4 |
D |
$5.85 |
$81,637 |
D/D |
(13,955) |
2,477,272 |
0 |
- |
|
| UAM |
Universal American Financ... |
Chief Executive Officer |
• • – |
2016-05-02 |
4 |
OE |
$5.98 |
$2,093,000 |
D/D |
350,000 |
2,300,478 |
0 |
- |
|
| UAM |
Universal American Financ... |
Chairman & CEO |
• • – |
2014-05-13 |
4 |
B |
$6.03 |
$1,239,901 |
D/D |
205,622 |
2,298,449 |
2.81 |
- |
|
| UAM |
Universal American Financ... |
Chairman & CEO |
• • – |
2014-05-13 |
4 |
B |
$6.03 |
$749,999 |
I/I |
124,378 |
220,768 |
2.66 |
- |
|
| UAM |
Universal American Financ... |
Chief Executive Officer |
• • – |
2016-02-13 |
4 |
D |
$6.06 |
$60,933 |
D/D |
(10,055) |
2,446,217 |
0 |
- |
|
| TOIIW |
Oncology Institute |
Director |
– • – |
2021-11-23 |
4 |
B |
$6.27 |
$31,699 |
D/D |
5,000 |
91,113 |
2.39 |
% |
|
| UAM |
Universal American Financ... |
Chief Executive Officer |
• • – |
2016-03-04 |
4 |
D |
$6.72 |
$75,022 |
D/D |
(11,164) |
1,950,478 |
0 |
- |
|
| UAM |
Universal American Financ... |
Chairman & CEO |
• • – |
2014-02-09 |
4 |
D |
$6.81 |
$93,501 |
D/D |
(13,730) |
2,103,991 |
0 |
- |
|
| TOIIW |
Oncology Institute |
Director |
– • – |
2021-11-24 |
4 |
B |
$6.81 |
$34,605 |
D/D |
5,000 |
96,113 |
2.39 |
% |
|
| UAM |
Universal American Financ... |
Chief Executive Officer |
• • – |
2016-05-02 |
4 |
D |
$7.25 |
$2,341,127 |
D/D |
(322,914) |
1,977,564 |
0 |
- |
|
| DFBHU |
DFB Healthcare Acquisitio... |
Interim CEO |
• • – |
2024-01-02 |
4 |
D |
$7.26 |
$66,981 |
D/D |
(9,226) |
439,410 |
0 |
- |
|
| UAM |
Universal American Financ... |
Chairman & CEO |
• • – |
2014-03-04 |
4 |
D |
$7.53 |
$84,065 |
D/D |
(11,164) |
2,092,827 |
0 |
- |
|
| UAM |
Universal American Financ... |
Chief Executive Officer |
• • – |
2017-02-06 |
4 |
OE |
$7.87 |
$3,148,000 |
D/D |
400,000 |
2,492,667 |
0 |
- |
|
74 Records found
|
|
Page 2 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
